Pituitary Adenylate Cyclase-Activating Polypeptide Protects Glomerular Podocytes from Inflammatory Injuries

Pituitary Adenylate Cyclase-Activating Polypeptide Protects Glomerular Podocytes from Inflammatory Injuries

Diabetic nephropathy (DN) is a leading cause of end-stage kidney disease; however, there are few treatment options. Inflammation plays a crucial role in the initiation and/or progression of DN. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide, which was originally isolate...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kenichi Sakamoto, Kyoko Kuno, Minoru Takemoto, Peng He, Takahiro Ishikawa, Shunichiro Onishi, Ryoichi Ishibashi, Emiko Okabe, Mayumi Shoji, Akiko Hattori, Masaya Yamaga, Kazuki Kobayashi, Harukiyo Kawamura, Hirotake Tokuyama, Yoshiro Maezawa, Koutaro Yokote
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2015/727152
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pituitary adenylate cyclase-activating polypeptide plays a role in neuropsychiatric and substance use disorders: sex-specific perspective
by: Catherine E. Van Doorn, et al.
Published: (2025-02-01)

Adenylate cyclase 10 promotes brown adipose tissue thermogenesis
by: Anupam Das, et al.
Published: (2025-02-01)

Microinfusion of Pituitary Adenylate Cyclase-Activating Polypeptide into the Central Nucleus of Amygdala of the Rat Produces a Shift from an Active to Passive Mode of Coping in the Shock-Probe Fear/Defensive Burying Test
by: Gabor Legradi, et al.
Published: (2007-01-01)

Regulation of the activity of adenylate cyclases by hydrogen peroxide in pea root cells Infected with pathogens and a mutualist
by: Olga V. Kuzakova, Lidia A. Lomovatskaya, Anatoly S. Romanenko, Alena M. Goncharova
Published: (2020-10-01)

Association of adenylate cyclase activity in vasopressor-type neurally mediated syncope based on the α2b-AR gene.
by: Tomoyoshi Komiyama, et al.
Published: (2025-01-01)

Pituitary adenylyl cyclase-activating polypeptide modulates the stress response: the involvement of different brain areas and microglia
by: Anika Singh, et al.
Published: (2025-01-01)

Polypeptide Expression in Prostate Hyperplasia and Prostate Adenocarcinoma
by: Ayodele Alaiya, et al.
Published: (2000-01-01)

Stimulators and Activators of Soluble Guanylate Cyclase: Review and Potential Therapeutic Indications
by: Bobby Nossaman, et al.
Published: (2012-01-01)

FXR Mediates Adenylyl Cyclase 8 Expression in Pancreatic β-Cells
by: Xiangchen Kong, et al.
Published: (2019-01-01)

Quantifying Podocyte Number in a Small Sample Size of Glomeruli with CUBIC to Evaluate Podocyte Depletion of db/db Mice
by: Jiaoyu Shi, et al.
Published: (2023-01-01)

Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer’s disease and correlates with tau pathology
by: Alessandro Padovani, et al.
Published: (2025-01-01)

The ADF/Cofilin-Pathway and Actin Dynamics in Podocyte Injury
by: Beina Teng, et al.
Published: (2012-01-01)

Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy
by: Lili Zhang, et al.
Published: (2020-01-01)

Chiral polypeptide hydrogels regulating local immune microenvironment and anti-tumor immune response
by: Junfeng Ding, et al.
Published: (2025-01-01)

Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
by: Yohei Asada, et al.
Published: (2019-01-01)

Xanthomonas citri subsp. citri requires a polyketide cyclase to activate the type III secretion system for virulence
by: Shuying Zhu, et al.
Published: (2025-02-01)

Thermal Synthesis of Polypeptides from N-Butyloxycarbonyl Oligopeptides Containing Aspartyl Residue at C-Terminus
by: Toratane Munegumi, et al.
Published: (2017-01-01)

Molecular Structure, Membrane Interactions, and Toxicity of the Islet Amyloid Polypeptide in Type 2 Diabetes Mellitus
by: Lucie Caillon, et al.
Published: (2016-01-01)

Urinary Podocyte Excretion Predicts Urinary Protein Selectivity and Renal Prognosis
by: Makoto Abe, et al.
Published: (2022-01-01)

Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonists for the treatment of obesity and diabetes mellitus
by: Alexander C. Martins, et al.
Published: (2024-04-01)

Human Islet Amyloid Polypeptide Fibril Binding to Catalase: A Transmission Electron Microscopy and Microplate Study
by: Nathaniel G. N. Milton, et al.
Published: (2010-01-01)

Polypeptide Globular Adiponectin Ameliorates Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Inhibiting Both Apoptosis and Necroptosis
by: Kaiyi Zhu, et al.
Published: (2021-01-01)

Recent Insight in Islet Amyloid Polypeptide Morphology, Structure, Membrane Interaction, and Toxicity in Type 2 Diabetes
by: Lucie Khemtemourian, et al.
Published: (2016-01-01)

The Development of a Novel Broad-Spectrum Influenza Polypeptide Vaccine Based on Multi-Epitope Tandem Sequences
by: Song Zhao, et al.
Published: (2025-01-01)

Process Optimization and Antioxidant Activity Analysis of White Kidney Bean Polypeptides Prepared by Composite Strain Fermentation
by: Sinan LI, et al.
Published: (2025-02-01)

Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy
by: Na Liu, et al.
Published: (2017-01-01)

Potential of peptides and phytochemicals in attenuating different phases of islet amyloid polypeptide fibrillation for type 2 diabetes management
by: Raliat O. Abioye, et al.
Published: (2021-05-01)

H. Pylori‐Facilitated TERT/Wnt/β‐Catenin Triggers Spasmolytic Polypeptide‐Expressing Metaplasia and Oxyntic Atrophy
by: Lijiao He, et al.
Published: (2025-01-01)

Advances in Focal Segmental Glomerulosclerosis Treatment From the Perspective of the Newest Mechanisms of Podocyte Injury
by: Zhu Y, et al.
Published: (2025-02-01)

Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes
by: Gina Manda, et al.
Published: (2015-01-01)

Sestrin2 Signaling Pathway Regulates Podocyte Biology and Protects against Diabetic Nephropathy
by: Moein Ala
Published: (2023-01-01)

Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy
by: Ruixia Ma, et al.
Published: (2021-01-01)

Upregulation of α3β1-Integrin in Podocytes in Early-Stage Diabetic Nephropathy
by: Kaichiro Sawada, et al.
Published: (2016-01-01)

Klotho Ameliorates Podocyte Injury through Targeting TRPC6 Channel in Diabetic Nephropathy
by: Xingmei Yao, et al.
Published: (2022-01-01)

Targeting endoplasmic reticulum stress: an innovative therapeutic strategy for podocyte-related kidney diseases
by: Jiao Lv, et al.
Published: (2025-01-01)

Pressure dependence of electron- and hole-consuming reactions in photocatalytic water splitting on Pt/TiO2 studied by time-resolved IR absorption spectroscopy
by: Akira Yamakata, et al.
Published: (2003-01-01)

REDD1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin-induced diabetic nephropathy
by: Siddharth Sunilkumar, et al.
Published: (2025-02-01)

Apoptosis-Inducing Factor, Protein Expression, and Apoptosis Changes with Glutamine in Podocytes Cells Exposed with Cisplatin
by: Imam Susilo, et al.
Published: (2021-01-01)

The potential role of differentially expressed tRNA-derived fragments in high glucose-induced podocytes
by: Zhenxing Zhang, et al.
Published: (2024-12-01)

RGD-HSA-TAC nanoparticles targeted delivery of tacrolimus and attenuation of podocyte injury in diabetic kidney disease
by: Zhaochen Guo, et al.
Published: (2025-02-01)